Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or Thalassemia

Provided herein are novel compounds, pharmaceutical compositions, use of such compounds in treating hemoglobinopathies, namely, anemia, sickle cell disease, or thalassemia, and processes for preparing such compounds.

Authors

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2025-12-18
DOI
https://doi.org/10.1021/acsmedchemlett.5c00730
Citations
1
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
1.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or Thalassemia

Ram W. Sabnis
1 citations
ACS Medicinal Chemistry Letters
Hemoglobinopathies and Related Disorders
1.63
article

Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or Thalassemia

Ram W. Sabnis
article en
1 citations

Abstract

Provided herein are novel compounds, pharmaceutical compositions, use of such compounds in treating hemoglobinopathies, namely, anemia, sickle cell disease, or thalassemia, and processes for preparing such compounds.

ACS Medicinal Chemistry LettersVol. 17(1)
Openalex Percentile: Top 11%
Hemoglobinopathies and Related Disorders
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or Thalassemia — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2025) | TGRS Research Map | TGRS